Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.

Lupus - 1 Oct 2022

Cotton Thaisa, Fritzler Marvin J, Choi May Y, Zheng Boyang, Niaki Omid Zahedi, Pineau Christian A, Lukusa Luck, Bernatsky Sasha

Abstract excerpt

OBJECTIVES: To determine if serologic phenotypes could be identified in systemic lupus erythematosus patients developing interstitial lung disease (ILD) and/or myositis. METHODS: Adult SLE patients (without myositis/ILD at baseline) had annual assessments and serum sampling between 2000 and 2017. New-onset ILD was identified using the SDI pulmonary fibrosis item. New-onset myositis was identified using the SLICC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Creatinine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Diseases, Interstitial

Share to Lupus Erythematosus, Systemic

Share to Muscle Weakness

Share to Myositis

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 36018314
DOI: 10.1177/09612033221122158
PMCID: PMC9580032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.PMID 36018314Read ↗

Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.Semantic proximity Read ↗

The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.Semantic proximity Read ↗

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.Semantic proximity Read ↗

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.Semantic proximity Read ↗

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.Semantic proximity Read ↗

Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional studySemantic proximity Read ↗

Comparison of Clinical Features and Prognostic Factors of Polymyositis/Dermatomyositis Associated Interstitial Lung Disease According to Autoantibodies: Anti-Aminoacyl tRNA Synthetase Antibodies Versus Anti-Melanoma Differentiation-Associated Gene 5 Antibody.Semantic proximity Read ↗

Autoimmune-Associated Interstitial Lung Disease: Imaging Phenotypes.Semantic proximity Read ↗

Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s SyndromeSemantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

Integrated classification of inflammatory myopathiesSemantic proximity Read ↗

Antibodies against Small Ubiquitin-Like Modifier Activating Enzyme Might Be A Protective Factor from Rapid Progressive Interstitial Lung Disease in Patients Bearing Antibodies against Melanoma Differentiation Associated Gene 5Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.